#GERN

Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to

3 months ago

#GERN Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation

www.stocktitan.net/news/GERN/geron-corporat...

0 0 0 0

Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies Geron (Nasdaq: GERN) announced five presentations accepted for ASH 2025 (Dec 6-9, Orlando) reporting new clinical and translational analyses of RYTELO (imetelstat) in lower-risk myelodysplastic syndromes (LR-MDS) and myelofibrosis (MF).Highlights include an oral IMerge Phase 3 analysis linking treatment-emergent cytopenias to clinical response in LR-MDS (Dec 7), a long-term IMerge poster with a ≥42-month overall survival trend versus placebo (Dec 6), MF biomarker and cytokine-response analyses from IMbark, an IMproveMF combination trial update, and an investigator-led interim IMpress study in high-risk MDS/AML.

4 months ago

#GERN Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies

www.stocktitan.net/news/GERN/geron-corporat...

0 0 0 0

Geron Reports Surging Q2 Revenue Growth as New CEO Takes Helm: Key Financial Metrics Revealed Discover Geron's Q2 transformation with significant revenue growth and strategic leadership change. See how RYTELO sales and pipeline progress impact bottom line.

7 months ago

#GERN Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights

www.stocktitan.net/news/GERN/geron-corporat...

0 0 0 0

Emma Woodhouse

@emmawoodhouse.bsky.social

7 months ago

#Gern
Ich leide nicht gern, aber daran leide ich, nämlich, wenn ich eingeladen werde, etwas GERN zu tun:

-Schalten Sie gern die ZIB2 ein
-Hören Sie gern unseren Podcast
-Lesen Sie gern den folgenden
Beitrag

Ergänzt gern die Liste!

3 1 2 0

Robert Kis - Textilkünstler

@textilkunst.bsky.social

9 months ago

Gobelin Stickerei "Stadt aus Licht"

"Geduld" - Textilkunst Ausstellung
Stadtteilwoche Neuhausen-Nymphenburg
Hirschgarten, Pavillon nähe Wasserspielplatz
03.07. bis 09.07.2025
Unter der Woche 16.00 bis 19.00 Uhr
Wochenende 12.00 bis 19.00 Uhr
stadtteilwochen-muenchen.de
#stadtteilwochen2025 #nymphenburg #gern #münchen #robertkis

1 0 0 0

Seitenstrasse

@sebastianteister.bsky.social

9 months ago

Stellen wir mal das #Licht ein ..

.. was für ein #Setting hätten Sie denn #gern ? Machen Sie sich keine #Sorgen ! Es ist für alles #gesorgt

0 0 0 0

Value The Markets

@valuethemarkets.bsky.social

9 months ago

Geron ($GERN) sees a 10% rebound in Rytelo demand after a Q1 dip. With a 20% sales team expansion and EU launch plans, is $GERN set for growth?

Full analysis ⬇️
www.valuethemarkets.com/analysis/ger...

#GERN #BiotechStocks #CancerResearch #InvestingNews #ValueTheMarkets

0 0 0 0

Nasdaq

@nasdaq.activitypub.awakari.com.ap.brid.gy

10 months ago

www.fool.com/investing/2025/05/07/why...

#GERN #45a2e0a2-3405-4ea4-a46a-9bb915d40ddf #investing

Result Details

0 0 0 0

Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights Geron Corporation (GERN) reported Q1 2025 financial results, with RYTELO® net product revenue of $39.4M, down from $47.5M in Q4 2024 due to inventory drawdown. The company posted a net loss of $19.8M ($0.03 per share), improved from $55.4M loss in Q1 2024. Key highlights include: European Commission marketing authorization for RYTELO for lower-risk MDS treatment, with EU launch planned for 2026; approximately 85% enrollment in Phase 3 IMpactMF trial for myelofibrosis, with interim analysis expected in 2H 2026. Cash position stands at $457.5M as of March 31, 2025. Operating expenses were $56.3M, with the company maintaining its 2025 guidance of $270-285M in total operating expenses.

10 months ago

#GERN Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights

www.stocktitan.net/news/GERN/geron-corporat...

0 0 0 0

irgenwie im sowieso

@irgenwieimsowieso.bsky.social

10 months ago

Die erste Mass in diesem Jahr
#volksfest
#gern
#dult
Man sagt es wär das älteste.

1 0 0 0

Class Action Suit Against Geron Corporation: Essential Update for Shareholders The Gross Law Firm has issued a notice regarding a class action lawsuit against Geron Corporation. Shareholders are encouraged to register before the deadline to protect their rights.

10 months ago

Class Action Suit Against Geron Corporation: Essential Update for Shareholders #USA #New_York #Class_Action #Geron_Corporation #GERN

0 0 0 0

Geron Corporation Faces Class Action Lawsuit Over Securities Fraud Allegations Investors in Geron Corporation are notified about a class action lawsuit regarding alleged securities fraud. Find out how to participate and your rights as an investor.

11 months ago

Geron Corporation Faces Class Action Lawsuit Over Securities Fraud Allegations #United_States #New_York #Securities_Fraud #Geron_Corporation #GERN

0 0 0 0

Important Information for Geron Corporation Shareholders Regarding Upcoming Class Action Lawsuit Shareholders of Geron Corporation are urged to connect with Levi & Korsinsky to discuss their rights related to a class action lawsuit concerning alleged securities fraud. Find out how to participate.

11 months ago

Important Information for Geron Corporation Shareholders Regarding Upcoming Class Action Lawsuit #USA #New_York #Levi_&_Korsinsky #Geron_Corporation #GERN

0 0 0 0

Investors Encouraged to Lead Geron Corporation Securities Lawsuit: DJS Law Group Offers Support DJS Law Group invites investors affected by Geron Corporation's misleading statements to join a class action lawsuit. Learn more about your rights.

11 months ago

Investors Encouraged to Lead Geron Corporation Securities Lawsuit: DJS Law Group Offers Support #USA #DJS_Law_Group #Eastchester #Geron_Corporation #GERN

0 0 0 0

Geron Reshapes Leadership After FDA Win: CEO Exits as RYTELO Launch Takes Center Stage Fresh leadership at Geron as Dawn Carter Bir steps in as interim CEO following RYTELO's FDA approval. Strategic shift focuses on commercial expansion in oncology therapeutics.

1 year ago

#GERN Geron Corporation Announces Departure of Chief Executive Officer

www.stocktitan.net/news/GERN/geron-corporat...

0 0 0 0

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

1 year ago

Most searched small-cap stocks, Wed Feb 26th - #EXK #DNUT #COMM #AG #FLYW #BTBT #BTE #PRCH #APLD #BBAI #WULF #GERN #UEC #SMR #RGTI #REAL #QBTS #MULN #CDE #AMR - More: crystalequityresearch.com/SmCpStr/ - #smallcap

0 0 0 0

Can Geron's $47.5M RYTELO Revenue Transform This Cancer Treatment Company? Geron achieved $76.5M in RYTELO revenue since June launch, secured positive European opinion, and maintains $502.9M cash position despite ongoing losses.

1 year ago

#GERN Geron Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

www.stocktitan.net/news/GERN/geron-corporat...

0 0 0 0

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

1 year ago

Most searched small-cap stocks, Mon Feb 24th - #BBAI #BGS #MLGO #QBTS #RGTI #GERN #YYAI #WULF #APLD #IQ #FUBO #RIG #TIGR #WOLF #FSM #VRN #RILY #CORZ #JBLU - More: crystalequityresearch.com/SmCpStr/ - #smallcap

1 0 0 0

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

1 year ago

Most searched small-cap stocks, Mon Feb 10th - #KULR #MBOT #IVVD #QBTS #EH #BB #LAES #RR #LUNR #WULF #OPK #RXRX #POWL #DOMH #SMR #PLRX #PLYA #BDRX #MNTS #GERN - More: crystalequityresearch.com/SmCpStr/ - #smallcap

1 0 0 0

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

1 year ago

Most searched small-cap stocks, Wed Feb 5th - #GERN #VBN #RNAZ #QNTM #FUBO #AG #LAES #RXRX #BB #WULF #BTE #BTG #CPIX #KTTA #IREN #SMR #QBTS #PTON #CDE #BBAI - More: crystalequityresearch.com/SmCpStr/ - #smallcap

0 0 0 0

Q4 Earnings Preview: Geron Sets Critical Financial Results Date - Key Details Inside Geron announces Q4 and full-year 2024 earnings release scheduled for February 26, featuring pre-market results and an 8 AM ET conference call with management presentation.

1 year ago

#GERN Geron to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

www.stocktitan.net/news/GERN/geron-to-annou...

0 0 0 0

Crystal Rogers, PhD

@rogerslabucd.bsky.social

1 year ago

Flyer for the MBL Gene Networks for Regulatory Development Course which will be held April 6-18, 2025.

Description of the MBL Gene Networks for Regulatory Development Course.

Happy Monday! The @mblscience.bsky.social #GERN gene regulatory networks course has extended its application deadline to January 20! If you are interested in gene regulation or gene networks- please apply! www.mbl.edu/education/ad...

5 2 0 0

InsiderFinance

@insiderfinance.com

1 year ago

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#MPC, #CMTL, #GERN, #ASPN, #RYN

#OptionFlow #OptionsTrading #Trading

1 0 0 0

Geron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS Geron (Nasdaq: GERN) received a positive opinion from the European Medicines Agency's CHMP recommending the approval of RYTELO (imetelstat) for treating adult patients with transfusion-dependent anemia due to lower-risk myelodysplastic syndromes (LR-MDS). The treatment is specifically for patients without an isolated deletion 5q cytogenetic abnormality who had unsatisfactory response to or are ineligible for erythropoietin-based therapy.The recommendation is based on the IMerge Phase 3 clinical trial results, which demonstrated reduced need for red blood cell transfusions in the first 24 weeks compared to placebo. If approved by the European Commission, RYTELO would become the first telomerase inhibitor available in Europe, administered as 47 mg and 188 mg lyophilized powder for intravenous infusion.

1 year ago

#GERN Geron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS

www.stocktitan.net/news/GERN/geron-announce...

0 0 0 0